“Lazarus Response” to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion

This report describes an estrogen receptor-positive breast cancer patient, who relapsed at two and a half years after the completion of adjuvant chemotherapy while being on the aromatase inhibition. Based on the clinical evidence for potential sensitivity of the tumor to hormone ablation, everolimus...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cureus
Main Authors: Moiseyenko, Vladimir M, Chubenko, Vyacheslav A, Moiseyenko, Fedor V, Zagorskaya, Lyudmila A, Zaytseva, Yuliya A, Gesha, Nataliya E, Zykov, Evgeny N, Ni, Valeriya I, Preobrazhenskaya, Elena V, Sokolenko, Anna P, Imyanitov, Evgeny N
Formato: Artigo
Idioma:Inglês
Publicado em: Cureus 2018
Assuntos:
Genetics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890964/
https://ncbi.nlm.nih.gov/pubmed/29651367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2150
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados